Table 2.
Treatment group | TC (mg/dl) | TG (mg/dl) | HDL (mg/dl) | LDL (mg/dl) | VLDL (mg/dl) |
---|---|---|---|---|---|
Control | 109.83±3.94 | 59.01±2.74 | 55.18±2.40 | 42.84±3.22 | 11.80±0.54 |
CCl4 | 206.00±4.53***a | 151.16±4.61***a | 26.25±1.79***a | 149.51±4.28***a | 30.23±0.92***a |
A. javanica (100 mg) + CCl4 | 163.33±5.28***b | 105.85±5.20***b | 29.76±1.02b | 112.39±6.82***b | 21.17±1.04***b |
A. javanica (200 mg) + CCl4 | 143.66±5.47***b | 82.61±3.65** b | 35.41±2.26**b | 91.72±6.25***b | 16.52±0.70***b |
Silymarin (10 mg) + CCl4 | 147.66±4.88***b | 110.16±5.26***b | 40.41±2.97**b | 85.21±5.98***b | 22.02±1.05***b |
All values represent mean±SEM
P<0.05
P<0.01
P<0.001; ANOVA, followed by Dunnet's multiple comparison test.
As compared with normal group.
As compared with CCl4-only group.